Bellevue Group AG

$4.2B reported 13(f) long value · latest quarter 2026-03-31 · CIK 1674546 · EDGAR ↗

sum of disclosed values for 2026-03-31; 0 positions carry a NULL value and are excluded from the sum, surfaced here rather than folded away: $4.2B
ALL retained default holdings for this (filer, period), including NULL-value ones: 167
positions with no comparable holding in the prior quarter (kind new), 2026-03-31: 19
positions absent from this quarter's filing after being held last quarter (kind exit), 2026-03-31 — inferred from absence, not a sale record: 40

A quarter-end snapshot. Filed up to 45 days later, so this page is not current holdings and never a complete portfolio. what a 13F is — and is not ↓ methodology §13F ↗

Position changes — into 2026-03-31

by shares · Δ value · filing link · how changes are classified §

Position changes into quarter 2026-03-31
position matched across quarters by exact reported CUSIP over a registry gap — producer-reconciled identity, never a name match `identity_reconciled_by_cusip`	the reported share count is unchanged across the pair; this build's data classified the change from its reported value; builds from 2026-09-10 on read it as NO CHANGE `classified_by_value` · EXIT = absent this quarter: disposed, delisted, under confidential treatment, or reported instead by an affiliated manager — the filing does not say which · change not classifiable: value undisclosed on one side of the quarter pair, or neither shares nor value can classify it · NO CHANGE = the share count is identical in both quarters; the value moved only with price, so the row is mark-to-market and never an ADD or a TRIM (NEW / ADD / TRIM / EXIT / NO CHANGE) · NO PRIOR = this filer has no comparable holdings list for the previous quarter on record — a first filing under this registration, or a quarter reported inside an affiliated manager's filing — so the position is not called a new stake	derived by Public Filings from the published aggregate; NULL means the source did not disclose a usable value — never zero	reported unit changed across the pair (SH↔PRN); the share delta is withheld rather than fabricated `shares_unit_mismatch`	Prev value	Curr value	Prev shares	Curr shares
position key `pos:10586` · issuer key `iss:1908` COM	ADD	−$4.3M	+788	$309M	$304M	681,120	681,908
position key `pos:17260` · issuer key `iss:165` SPONSORED ADR	TRIM	−$160M	−148,854	$388M	$229M	461,854	313,000
position key `pos:15140` · issuer key `iss:1537` COM	ADD	+$205M	+264,746	$10.8M	$215M	13,928	278,674
position key `pos:17712` · issuer key `iss:1630` COM	TRIM	−$2.5M	−472,019	$179M	$176M	4,056,592	3,584,573
position key `pos:10600` · issuer key `iss:821` COM	ADD	+$157M	+1,117,127	$6.5M	$163M	52,752	1,169,879
position key `pos:14656` · issuer key `iss:1552` COM	TRIM	−$249M	−3,461,263	$399M	$150M	5,005,719	1,544,456
position key `pos:11517` · issuer key `iss:1003` COM	TRIM	−$243M	−2,983,534	$380M	$137M	4,802,199	1,818,665
position key `pos:16805` · issuer key `iss:997` COM NEW	TRIM	−$50.2M	−35,374	$182M	$132M	322,028	286,654
position key `sid:sec:prov:4b145c10f034612809a5ead021971789` · issuer key `cusip6:92790C` COM	ADD	−$4.1M	+2,367,617	$136M	$132M	4,358,527	6,726,144
position key `pos:16881` · issuer key `iss:1079` COM	ADD	+$23.3M	+71,462	$101M	$124M	410,323	481,785
position key `pos:14981` · issuer key `iss:535` COM	ADD	+$119M	+3,275,960	$188K	$119M	4,040	3,280,000
position key `pos:12366` · issuer key `iss:22` COM	TRIM	−$46.8M	−165,280	$165M	$118M	1,316,915	1,151,635
position key `pos:13206` · issuer key `iss:1335` COM	ADD	+$3.5M	+15,800	$104M	$108M	1,037,468	1,053,268
position key `pos:11671` · issuer key `iss:122` COM	ADD	+$97.9M	+276,869	$6.1M	$104M	18,489	295,358
position key `pos:14095` · issuer key `iss:307` COM	TRIM	−$56.7M	−92,712	$149M	$92.0M	1,559,606	1,466,894
position key `sid:sec:prov:bf437640b37b30ed62d091e5e9de5808` · issuer key `cusip6:29337E` COM	NEW	+$91.0M	+2,320,867	$0	$91.0M	—	2,320,867
position key `pos:13406` · issuer key `iss:2156` SHS	ADD	+$9.3M	+190,737	$73.6M	$83.0M	766,592	957,329
position key `pos:15131` · issuer key `iss:87` COM	TRIM	−$99.7M	−211,360	$177M	$77.6M	445,903	234,543
position key `pos:12369` · issuer key `iss:1540` COM	TRIM	+$7.0M	−550,122	$70.6M	$77.6M	8,345,364	7,795,242
position key `pos:15220` · issuer key `iss:1725` COM	TRIM	−$55.4M	−143,340	$127M	$71.4M	360,577	217,237
position key `pos:11660` · issuer key `iss:1893` COM	NEW	+$69.2M	+1,190,697	$0	$69.2M	—	1,190,697
position key `sid:sec:prov:c6f0567aff349dfe2dab4a6ee5ba8988` · issuer key `cusip6:92337R` CL A	ADD	−$17.2M	+12,619	$86.0M	$68.8M	1,698,152	1,710,771
position key `pos:16440` · issuer key `iss:637` COM	TRIM	−$21.7M	−203,645	$88.9M	$67.2M	1,043,096	839,451
position key `pos:16214` · issuer key `iss:797` COM NEW	NEW	+$59.5M	+2,298,000	$0	$59.5M	—	2,298,000
position key `pos:11535` · issuer key `iss:1757` COM	TRIM	+$15.4M	−1,527,670	$34.8M	$50.2M	3,927,670	2,400,000
position key `pos:16368` · issuer key `iss:953` COM	TRIM	−$13.9M	−5,408	$64.0M	$50.1M	94,539	89,131
position key `pos:15677` · issuer key `iss:1851` COM	ADD	+$49.8M	+2,377,420	$59.3K	$49.9M	2,580	2,380,000
position key `pos:15034` · issuer key `iss:573` COM	TRIM	−$6.7M	−58,639	$56.2M	$49.5M	847,405	788,766
position key `sid:sec:prov:3b4a08cf659449a1ac1d2ee41e501b50` · issuer key `cusip6:008064` COM NEW	ADD	−$2.4M	+160,399	$51.6M	$49.2M	3,341,103	3,501,502
position key `pos:16115` · issuer key `iss:1869` COM	TRIM	−$17.7M	−26,966	$57.8M	$40.1M	175,169	148,203
position key `pos:15144` · issuer key `iss:556` COM	ADD	−$6.2M	+7,531	$44.6M	$38.3M	194,633	202,164
position key `sid:sec:prov:30f8f229420c7a82ec2ecf2f2f622045` · issuer key `cusip6:15117B` COM NEW	TRIM	−$60.2M	−2,417,669	$98.3M	$38.1M	3,617,669	1,200,000
position key `pos:16392` · issuer key `iss:1549` COM	TRIM	−$3.1M	−1,868	$38.8M	$35.8M	161,214	159,346
position key `pos:17234` · issuer key `iss:981` COM	TRIM	−$18.7M	−23,043	$53.1M	$34.3M	186,699	163,656
position key `pos:15125` · issuer key `iss:1798` COM	TRIM	−$6.0M	−665	$37.7M	$31.7M	65,077	64,412
position key `pos:15863` · issuer key `iss:1123` COM	TRIM	−$5.3M	−71	$36.5M	$31.2M	34,003	33,932
position key `pos:16356` · issuer key `iss:795` COMMON STOCK	TRIM	−$5.1M	−7,627	$34.8M	$29.7M	424,514	416,887
position key `pos:12161` · issuer key `iss:587` COM	NEW	+$29.4M	+459,314	$0	$29.4M	—	459,314
position key `pos:13599` · issuer key `iss:1035` COM	TRIM	+$2.9M	−7,698	$26.2M	$29.1M	126,800	119,102
position key `pos:15492` · issuer key `iss:355` COM	TRIM	−$4.1M	−11,750	$30.3M	$26.2M	110,013	98,263
position key `pos:13812` · issuer key `iss:1378` COM	NEW	+$24.9M	+507,008	$0	$24.9M	—	507,008
position key `pos:17751` · issuer key `iss:1214` COM	ADD	+$15.2M	+114,474	$9.7M	$24.9M	92,117	206,591
position key `pos:14053` · issuer key `iss:73` COM	TRIM	+$1.9M	−1,794	$22.1M	$23.9M	141,474	139,680
position key `pos:13247` · issuer key `iss:2223` SHS USD	TRIM	−$3.7M	−1,827	$25.8M	$22.1M	101,705	99,878
position key `pos:17000` · issuer key `iss:829` CL A	TRIM	−$1.6M	−15,422	$22.9M	$21.3M	262,683	247,261
position key `sid:sec:prov:3224bd4d4c1e7dd823e99e6304f866c2` · issuer key `cusip6:61225M` COM	NEW	+$20.6M	+1,250,000	$0	$20.6M	—	1,250,000
position key `pos:15499` · issuer key `iss:23` COM	TRIM	−$10.5M	−41,292	$30.8M	$20.3M	134,859	93,567
position key `pos:17009` · issuer key `iss:510` COM	TRIM	−$4.5M	−19,775	$23.9M	$19.5M	291,959	272,184
position key `pos:17201` · issuer key `iss:1208` COM	TRIM	−$1.2M	−2,746	$20.6M	$19.3M	25,098	22,352
position key `pos:15545` · issuer key `iss:247` COM	TRIM	−$32.4M	−143,775	$51.6M	$19.2M	265,662	121,887
position key `pos:16411` · issuer key `iss:865` COM	TRIM	−$2.6M	−6,141	$20.5M	$17.9M	43,906	37,765
position key `pos:15808` · issuer key `iss:825` COM	TRIM	−$13.9M	−116,232	$29.6M	$15.7M	261,935	145,703
position key `pos:15047` · issuer key `iss:135` COM	TRIM	−$9.0M	−17,127	$24.4M	$15.4M	69,645	52,518
position key `pos:12417` · issuer key `iss:2008` COM	TRIM	−$7.4M	−83,109	$21.5M	$14.1M	238,680	155,571
position key `sid:sec:prov:84385008a6354d52d8f431948b8d3d1e` · issuer key `cusip6:74276L` COM	TRIM	−$3.7M	−13,144	$16.2M	$12.6M	515,430	502,286
position key `pos:10996` · issuer key `iss:2155` SHS	NEW	+$11.8M	+186,185	$0	$11.8M	—	186,185
position key `pos:10550` · issuer key `iss:929` COM	TRIM	−$7.5M	−8,583	$18.7M	$11.2M	73,081	64,498
position key `pos:17678` · issuer key `iss:1814` COM	ADD	−$1.9M	+3,254	$11.9M	$10.1M	97,885	101,139
position key `pos:13364` · issuer key `iss:1894` CL A COM	TRIM	−$8.0M	−24,012	$18.0M	$9.9M	80,529	56,517
position key `pos:12687` · issuer key `iss:419` COM	TRIM	−$2.7M	−12,608	$11.3M	$8.5M	273,674	261,066
position key `pos:14866` · issuer key `iss:1787` SPONSORED ADS	TRIM	−$2.7M	−77,781	$10.2M	$7.5M	327,863	250,082
position key `pos:17130` · issuer key `iss:1776` COM NEW	TRIM	−$775K	−1,970	$8.0M	$7.2M	40,239	38,269
position key `pos:10371` · issuer key `iss:1774` CL A COM	ADD	+$1.7M	+7,432	$5.3M	$7.0M	322,060	329,492
position key `pos:13354` · issuer key `iss:367` COM	TRIM	−$2.2M	−19,695	$8.7M	$6.4M	109,058	89,363
position key `pos:13186` · issuer key `iss:1273` COM	TRIM	−$6.5M	−24,342	$12.8M	$6.3M	56,036	31,694
position key `pos:15030` · issuer key `iss:1951` COM	ADD	−$1.7M	+14,405	$7.9M	$6.2M	241,734	256,139
position key `pos:15409` · issuer key `iss:1212` COM CL A	ADD	+$1.1M	+18,915	$4.9M	$6.1M	117,720	136,635
position key `pos:13569` · issuer key `iss:975` COM	TRIM	−$4.1M	−1,026	$9.3M	$5.1M	100,761	99,735
position key `pos:15014` · issuer key `iss:1487` COM	TRIM	−$6.0M	−221,460	$10.6M	$4.7M	448,163	226,703
position key `pos:10385` · issuer key `iss:1433` COM	TRIM	−$38.1M	−123,128	$42.1M	$4.0M	135,395	12,267
position key `pos:10611` · issuer key `iss:190` COM	NEW	+$3.5M	+263,096	$0	$3.5M	—	263,096
position key `pos:10790` · issuer key `iss:1444` COM	ADD	+$1.6M	+50,788	$1.4M	$3.0M	56,847	107,635
position key `pos:14627` · issuer key `iss:955` COM	TRIM	−$516K	−2,717	$3.0M	$2.5M	22,940	20,223
position key `sid:sec:prov:369e1c5681e056c6b774b8d85dbdd346` · issuer key `cusip6:G52441` SHS	TRIM	−$766K	−165	$3.1M	$2.3M	115,755	115,590
position key `sid:sec:prov:748c3ea2043f7dae881221f3c766e002` · issuer key `cusip6:68170A` COM	TRIM	−$822K	−19,959	$2.8M	$2.0M	177,897	157,938
position key `pos:14584` · issuer key `iss:311` COM	ADD	+$40.2K	+1,266	$1.8M	$1.9M	24,111	25,377
position key `pos:15139` · issuer key `iss:270` SPONSORED ADS	TRIM	−$2.3M	−22,904	$4.2M	$1.9M	43,755	20,851
position key `pos:18031` · issuer key `iss:2202` SHS CLASS A	ADD	+$1.3M	+25,095	$510K	$1.8M	13,201	38,296
position key `pos:11570` · issuer key `iss:1599` TR UNIT	TRIM	−$358K	−400	$2.1M	$1.8M	3,100	2,700
position key `pos:14207` · issuer key `iss:973` COM PAR $.01	TRIM	−$781K	−3,881	$2.4M	$1.6M	13,915	10,034
position key `pos:14357` · issuer key `iss:1170` COM	ADD	−$88.1K	+156	$1.7M	$1.6M	2,884	3,040
position key `sid:sec:prov:003ec1a792a63a6ca1608977e0029001` · issuer key `cusip6:574795` COM	TRIM	−$11.1M	−88,532	$12.7M	$1.6M	97,285	8,753
position key `pos:13950` · issuer key `iss:1497` COM	TRIM	+$77.8K	−2,096	$1.4M	$1.5M	16,543	14,447
position key `pos:15016` · issuer key `iss:1868` COM	TRIM	−$666K	−1,818	$1.9M	$1.2M	3,895	2,077
position key `pos:14374` · issuer key `iss:248` SPONSORED ADS	ADD	+$558K	+1,922	$574K	$1.1M	1,890	3,812
position key `pos:13858` · issuer key `iss:1450` COM	TRIM	−$2.0M	−52,221	$3.1M	$1.1M	183,213	130,992
position key `pos:15323` · issuer key `iss:37` COM	TRIM	−$3.8M	−221,909	$4.8M	$1.1M	298,090	76,181
position key `pos:15008` · issuer key `iss:318` COM	TRIM	−$2.6M	−50,044	$3.6M	$1.0M	67,082	17,038
position key `pos:17319` · issuer key `iss:652` COM	TRIM	−$1.1M	−9,260	$2.0M	$951K	19,089	9,829
position key `pos:16384` · issuer key `iss:2294` ORDINARY SHARES	TRIM	−$389K	−8,675	$1.3M	$885K	36,336	27,661
position key `pos:18210` · issuer key `iss:263` CL A	TRIM	−$33.5K	−35	$867K	$833K	10,589	10,554
position key `sid:sec:prov:d00159df48fd34cc806ae902a076ba0a` · issuer key `cusip6:603170` COM	ADD	+$76.3K	+9,548	$719K	$796K	19,826	29,374
position key `pos:16474` · issuer key `iss:675` SPONSORED ADR	NEW	+$742K	+17,573	$0	$742K	—	17,573
position key `pos:14552` · issuer key `iss:711` COM	NEW	+$741K	+4,370	$0	$741K	—	4,370
position key `pos:16000` · issuer key `iss:215` SPONSORED ADR	NEW	+$735K	+15,644	$0	$735K	—	15,644
position key `pos:14503` · issuer key `iss:1578` SPON ADS	NEW	+$729K	+7,844	$0	$729K	—	7,844
position key `sid:sec:prov:4e7eb09ab13c64fd6730ede8dbc988b8` · issuer key `cusip6:08659B` COM	TRIM	−$1.5M	−133	$2.2M	$723K	72,285	72,152
position key `pos:11450` · issuer key `iss:267` COM	ADD	+$42.3K	+88	$627K	$670K	3,565	3,653
position key `sid:sec:prov:235b0febe313b5e3f4a7bc8d76a41721` · issuer key `cusip6:52490G` SPONSORED ADS	TRIM	−$742K	−28,085	$1.4M	$649K	63,971	35,886
position key `pos:11462` · issuer key `iss:1296` COM	TRIM	−$241M	−1,698,658	$242M	$612K	1,703,304	4,646

Flags: no row carries a flag.

1–20 of the 100 changes on this page

Mark-to-market only (no share change) · 15

Positions whose share count is identical in both quarters; the value changed with price, not with a decision.

Positions held with no share change into quarter 2026-03-31
position matched across quarters by exact reported CUSIP over a registry gap — producer-reconciled identity, never a name match `identity_reconciled_by_cusip`	the reported share count is unchanged across the pair; this build's data classified the change from its reported value; builds from 2026-09-10 on read it as NO CHANGE `classified_by_value` · EXIT = absent this quarter: disposed, delisted, under confidential treatment, or reported instead by an affiliated manager — the filing does not say which · change not classifiable: value undisclosed on one side of the quarter pair, or neither shares nor value can classify it · NO CHANGE = the share count is identical in both quarters; the value moved only with price, so the row is mark-to-market and never an ADD or a TRIM (NEW / ADD / TRIM / EXIT / NO CHANGE) · NO PRIOR = this filer has no comparable holdings list for the previous quarter on record — a first filing under this registration, or a quarter reported inside an affiliated manager's filing — so the position is not called a new stake	derived by Public Filings from the published aggregate; NULL means the source did not disclose a usable value — never zero	Prev value	Curr value	Prev shares	Curr shares
position key `pos:15541` · issuer key `iss:958` ADS	NO CHANGE	−$12.8M	$97.1M	$84.3M	2,796,803	2,796,803
position key `pos:11808` · issuer key `iss:635` COM	NO CHANGE	+$10.2M	$37.9M	$48.1M	1,528,518	1,528,518
position key `sid:sec:prov:45f58e3bf467aafd3516eb30bc85b601` · issuer key `cusip6:03589W` COM	NO CHANGE	+$2.7M	$25.9M	$28.6M	5,157,290	5,157,290
position key `pos:13215` · issuer key `iss:144` COM	NO CHANGE	−$60.0K	$903K	$843K	3,320	3,320
position key `pos:11944` · issuer key `iss:454` COM	NO CHANGE	+$4.5K	$616K	$621K	8,000	8,000
position key `pos:15694` · issuer key `iss:72` SPONSORED ADS	NO CHANGE	−$99.3K	$689K	$590K	4,700	4,700
position key `pos:14583` · issuer key `iss:428` COM	NO CHANGE	−$309K	$876K	$567K	99,442	99,442
position key `pos:14992` · issuer key `iss:1485` COM	NO CHANGE	+$4.4K	$559K	$563K	3,900	3,900
position key `pos:14206` · issuer key `iss:1193` CL A	NO CHANGE	−$78.3K	$628K	$550K	1,100	1,100
position key `pos:11610` · issuer key `iss:287` COM	NO CHANGE	−$48.9K	$482K	$433K	450	450
position key `pos:12848` · issuer key `iss:1921` COM CL A	NO CHANGE	−$67.9K	$491K	$423K	1,400	1,400
position key `pos:11844` · issuer key `iss:1030` SPON ADS CL A	NO CHANGE	+$9.6K	$316K	$325K	11,000	11,000
position key `pos:17429` · issuer key `iss:2052` SHS CLASS A	NO CHANGE	−$105K	$402K	$297K	1,500	1,500
position key `pos:17290` · issuer key `iss:39` COM	NO CHANGE	−$128K	$420K	$292K	1,200	1,200
position key `pos:14212` · issuer key `iss:396` COM	NO CHANGE	−$58.4K	$173K	$115K	6,418	6,418

Flags: no row carries a flag.

Newest filing in this build: 2026-07-31. Per-row filing dates are on each receipt.

Truncated by Public Filings. Changes compare every position with a security identifier, new and exited included; holdings without one are counted, not compared. methodology §13F ↗

Reported positions — 2026-03-31

1–100 of 155 issuers · $4.2B disclosed value over 167 rows · 0 undisclosed-value rows

View

This build carries one quarter for this manager: 2026-03-31. Notable managers carry four published quarters, others two.

This list carries reported issuer names and security identities, without a dated ticker mapping. Symbols are not inferred from names.

a position composed from a base filing plus NEW-HOLDINGS amendments keeps every source row here; the composition's latest filed date is the one shown served from this build's published holdings (derived from the filer's own reported rows); every row resolves to its filing

Share of total reported value, calculated only when the full position list has disclosed values. This is 13F long value, not total assets.

value undisclosed on the filing: retained and counted, excluded from sums, never shown as $0

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

VERTEX PHARMACEUTICALS INC

1 position · 2 reported rows

Rows Bellevue Group AG reported for VERTEX PHARMACEUTICALS INC, as it reported them
VERTEX PHARMACEUTICALS INC · COM CUSIP — src ↗	$298M	667,375
VERTEX PHARMACEUTICALS INC · COM CUSIP — src ↗	$6.5M	14,533

$304M

681,908

7.2%

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

ARGENX SE · SPONSORED ADR CUSIP —
2026-03-31 filed 2026-05-15 +45d

src ↗

$229M

313,000

5.4%

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

REGENERON PHARMACEUTICALS

1 position · 2 reported rows

Rows Bellevue Group AG reported for REGENERON PHARMACEUTICALS, as it reported them
REGENERON PHARMACEUTICALS · COM CUSIP — src ↗	$214M	277,132
REGENERON PHARMACEUTICALS · COM CUSIP — src ↗	$1.2M	1,542

$215M

278,674

5.1%

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

SCHOLAR ROCK HLDG CORP

1 position · 2 reported rows

Rows Bellevue Group AG reported for SCHOLAR ROCK HLDG CORP, as it reported them
SCHOLAR ROCK HLDG CORP · COM CUSIP — src ↗	$176M	3,579,278
SCHOLAR ROCK HLDG CORP · COM CUSIP — src ↗	$260K	5,295

$176M

3,584,573

4.2%

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

GILEAD SCIENCES INC

1 position · 2 reported rows

Rows Bellevue Group AG reported for GILEAD SCIENCES INC, as it reported them
GILEAD SCIENCES INC · COM CUSIP — src ↗	$156M	1,118,000
GILEAD SCIENCES INC · COM CUSIP — src ↗	$7.2M	51,879

$163M

1,169,879

3.9%

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

REVOLUTION MEDICINES INC

1 position · 2 reported rows

Rows Bellevue Group AG reported for REVOLUTION MEDICINES INC, as it reported them
REVOLUTION MEDICINES INC · COM CUSIP — src ↗	$150M	1,540,588
REVOLUTION MEDICINES INC · COM CUSIP — src ↗	$376K	3,868

$150M

1,544,456

3.6%

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

IONIS PHARMACEUTICALS INC

1 position · 2 reported rows

Rows Bellevue Group AG reported for IONIS PHARMACEUTICALS INC, as it reported them
IONIS PHARMACEUTICALS INC · COM CUSIP — src ↗	$134M	1,790,000
IONIS PHARMACEUTICALS INC · COM CUSIP — src ↗	$2.2M	28,665

$137M

1,818,665

3.2%

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

INTUITIVE SURGICAL INC · COM NEW CUSIP —
2026-03-31 filed 2026-05-15 +45d

src ↗

$132M

286,654

3.1%

—

VIRIDIAN THERAPEUTICS INC

1 position · 2 reported rows

Rows Bellevue Group AG reported for VIRIDIAN THERAPEUTICS INC, as it reported them
VIRIDIAN THERAPEUTICS INC · COM CUSIP 92790C104 src ↗	$131M	6,717,515
VIRIDIAN THERAPEUTICS INC · COM CUSIP 92790C104 src ↗	$169K	8,629

ticker not yet mapped

$132M

6,726,144

3.1%

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

KRYSTAL BIOTECH INC

1 position · 2 reported rows

Rows Bellevue Group AG reported for KRYSTAL BIOTECH INC, as it reported them
KRYSTAL BIOTECH INC · COM CUSIP — src ↗	$124M	480,322
KRYSTAL BIOTECH INC · COM CUSIP — src ↗	$378K	1,463

$124M

481,785

3.0%

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

CRINETICS PHARMACEUTICALS IN · COM CUSIP —
2026-03-31 filed 2026-05-15 +45d

src ↗

$119M

3,280,000

2.8%

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

ABBOTT LABORATORIES · COM CUSIP —
2026-03-31 filed 2026-05-15 +45d

src ↗

$118M

1,151,635

2.8%

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

NUVALENT INC · COM CUSIP —
2026-03-31 filed 2026-05-15 +45d

src ↗

$108M

1,053,268

2.6%

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

AMGEN INC

1 position · 2 reported rows

Rows Bellevue Group AG reported for AMGEN INC, as it reported them
AMGEN INC · COM CUSIP — src ↗	$94.3M	268,000
AMGEN INC · COM CUSIP — src ↗	$9.6M	27,358

$104M

295,358

2.5%

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

BOSTON SCIENTIFIC CORP · COM CUSIP —
2026-03-31 filed 2026-05-15 +45d

src ↗

$92.0M

1,466,894

2.2%

—

ENLIVEN THERAPEUTICS INC · COM CUSIP 29337E102
2026-03-31 filed 2026-05-15 +45d

src ↗

ticker not yet mapped

$91.0M

2,320,867

2.2%

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

IMMUNOCORE HLDGS PLC · ADS CUSIP —
2026-03-31 filed 2026-05-15 +45d

src ↗

$84.3M

2,796,803

2.0%

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

MEDTRONIC PLC · SHS CUSIP —
2026-03-31 filed 2026-05-15 +45d

src ↗

$83.0M

957,329

2.0%

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

ALNYLAM PHARMACEUTICALS INC

1 position · 2 reported rows

Rows Bellevue Group AG reported for ALNYLAM PHARMACEUTICALS INC, as it reported them
ALNYLAM PHARMACEUTICALS INC · COM CUSIP — src ↗	$77.3M	233,679
ALNYLAM PHARMACEUTICALS INC · COM CUSIP — src ↗	$286K	864

$77.6M

234,543

1.8%

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

RELAY THERAPEUTICS INC

1 position · 2 reported rows

Rows Bellevue Group AG reported for RELAY THERAPEUTICS INC, as it reported them
RELAY THERAPEUTICS INC · COM CUSIP — src ↗	$77.5M	7,793,318
RELAY THERAPEUTICS INC · COM CUSIP — src ↗	$19.1K	1,924

$77.6M

7,795,242

1.8%

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

STRYKER CORPORATION · COM CUSIP —
2026-03-31 filed 2026-05-15 +45d

src ↗

$71.4M

217,237

1.7%

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

VAXCYTE INC · COM CUSIP —
2026-03-31 filed 2026-05-15 +45d

src ↗

$69.2M

1,190,697

1.6%

—

VERA THERAPEUTICS INC

1 position · 2 reported rows

Rows Bellevue Group AG reported for VERA THERAPEUTICS INC, as it reported them
VERA THERAPEUTICS INC · CL A CUSIP 92337R101 src ↗	$68.1M	1,692,906
VERA THERAPEUTICS INC · CL A CUSIP 92337R101 src ↗	$719K	17,865

ticker not yet mapped

$68.8M

1,710,771

1.6%

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

EDWARDS LIFESCIENCES CORP · COM CUSIP —
2026-03-31 filed 2026-05-15 +45d

src ↗

$67.2M

839,451

1.6%

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

DAMORA THERAPEUTICS INC · COM NEW CUSIP —
2026-03-31 filed 2026-05-15 +45d

src ↗

$59.5M

2,298,000

1.4%

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

TANGO THERAPEUTICS INC · COM CUSIP —
2026-03-31 filed 2026-05-15 +45d

src ↗

$50.2M

2,400,000

1.2%

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

IDEXX LABS INC · COM CUSIP —
2026-03-31 filed 2026-05-15 +45d

src ↗

$50.1M

89,131

1.2%

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

ULTRAGENYX PHARMACEUTICAL IN · COM CUSIP —
2026-03-31 filed 2026-05-15 +45d

src ↗

$49.9M

2,380,000

1.2%

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

DEXCOM INC · COM CUSIP —
2026-03-31 filed 2026-05-15 +45d

src ↗

$49.5M

788,766

1.2%

—

JADE BIOSCIENCES INC · COM NEW CUSIP 008064206
2026-03-31 filed 2026-05-15 +45d

src ↗

ticker not yet mapped

$49.2M

3,501,502

1.2%

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

EDGEWISE THERAPEUTICS INC · COM CUSIP —
2026-03-31 filed 2026-05-15 +45d

src ↗

$48.1M

1,528,518

1.1%

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

UNITEDHEALTH GROUP INC · COM CUSIP —
2026-03-31 filed 2026-05-15 +45d

src ↗

$40.1M

148,203

1.0%

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

DANAHER CORP DEL · COM CUSIP —
2026-03-31 filed 2026-05-15 +45d

src ↗

$38.3M

202,164

0.9%

—

CELLDEX THERAPEUTICS INC NEW · COM NEW CUSIP 15117B202
2026-03-31 filed 2026-05-15 +45d

src ↗

ticker not yet mapped

$38.1M

1,200,000

0.9%

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

RESMED INC · COM CUSIP —
2026-03-31 filed 2026-05-15 +45d

src ↗

$35.8M

159,346

0.9%

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

INSULET CORP · COM CUSIP —
2026-03-31 filed 2026-05-15 +45d

src ↗

$34.3M

163,656

0.8%

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

THERMO FISHER SCIENTIFIC INC · COM CUSIP —
2026-03-31 filed 2026-05-15 +45d

src ↗

$31.7M

64,412

0.8%

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

ELI LILLY & CO · COM CUSIP —
2026-03-31 filed 2026-05-15 +45d

src ↗

$31.2M

33,932

0.7%

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

GE HEALTHCARE TECHNOLOGIES I · COMMON STOCK CUSIP —
2026-03-31 filed 2026-05-15 +45d

src ↗

$29.7M

416,887

0.7%

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

DISC MEDICINE INC · COM CUSIP —
2026-03-31 filed 2026-05-15 +45d

src ↗

$29.4M

459,314

0.7%

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

JOHNSON & JOHNSON · COM CUSIP —
2026-03-31 filed 2026-05-15 +45d

src ↗

$29.1M

119,102

0.7%

—

ANNEXON INC · COM CUSIP 03589W102
2026-03-31 filed 2026-05-15 +45d

src ↗

ticker not yet mapped

$28.6M

5,157,290

0.7%

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

THE CIGNA GROUP · COM CUSIP —
2026-03-31 filed 2026-05-15 +45d

src ↗

$26.2M

98,263

0.6%

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

ORUKA THERAPEUTICS INC · COM CUSIP —
2026-03-31 filed 2026-05-15 +45d

src ↗

$24.9M

507,008

0.6%

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

MERCK & CO INC · COM CUSIP —
2026-03-31 filed 2026-05-15 +45d

src ↗

$24.9M

206,591

0.6%

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

ALIGN TECHNOLOGY INC · COM CUSIP —
2026-03-31 filed 2026-05-15 +45d

src ↗

$23.9M

139,680

0.6%

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

STERIS PLC · SHS USD CUSIP —
2026-03-31 filed 2026-05-15 +45d

src ↗

$22.1M

99,878

0.5%

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

GLOBUS MED INC · CL A CUSIP —
2026-03-31 filed 2026-05-15 +45d

src ↗

$21.3M

247,261

0.5%

—

MONTE ROSA THERAPEUTICS INC · COM CUSIP 61225M102
2026-03-31 filed 2026-05-15 +45d

src ↗

ticker not yet mapped

$20.6M

1,250,000

0.5%

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

ABBVIE INC · COM CUSIP —
2026-03-31 filed 2026-05-15 +45d

src ↗

$20.3M

93,567

0.5%

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

COOPER COS INC · COM CUSIP —
2026-03-31 filed 2026-05-15 +45d

src ↗

$19.5M

272,184

0.5%

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

MCKESSON CORP · COM CUSIP —
2026-03-31 filed 2026-05-15 +45d

src ↗

$19.3M

22,352

0.5%

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

BECTON DICKINSON & CO · COM CUSIP —
2026-03-31 filed 2026-05-15 +45d

src ↗

$19.2M

121,887

0.5%

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

HCA HEALTHCARE INC · COM CUSIP —
2026-03-31 filed 2026-05-15 +45d

src ↗

$17.9M

37,765

0.4%

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

GLAUKOS CORP · COM CUSIP —
2026-03-31 filed 2026-05-15 +45d

src ↗

$15.7M

145,703

0.4%

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

ELEVANCE HEALTH INC FORMERLY · COM CUSIP —
2026-03-31 filed 2026-05-15 +45d

src ↗

$15.4M

52,518

0.4%

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

ZIMMER BIOMET HOLDINGS INC · COM CUSIP —
2026-03-31 filed 2026-05-15 +45d

src ↗

$14.1M

155,571

0.3%

—

PROCEPT BIOROBOTICS CORP · COM CUSIP 74276L105
2026-03-31 filed 2026-05-15 +45d

src ↗

ticker not yet mapped

$12.6M

502,286

0.3%

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

LIVANOVA PLC · SHS CUSIP —
2026-03-31 filed 2026-05-15 +45d

src ↗

$11.8M

186,185

0.3%

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

HUMANA INC · COM CUSIP —
2026-03-31 filed 2026-05-15 +45d

src ↗

$11.2M

64,498

0.3%

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

TRANSMEDICS GROUP INC · COM CUSIP —
2026-03-31 filed 2026-05-15 +45d

src ↗

$10.1M

101,139

0.2%

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

VEEVA SYS INC · CL A COM CUSIP —
2026-03-31 filed 2026-05-15 +45d

src ↗

$9.9M

56,517

0.2%

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

CENTENE CORP DEL · COM CUSIP —
2026-03-31 filed 2026-05-15 +45d

src ↗

$8.5M

261,066

0.2%

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

TEVA PHARMACEUTICAL INDS LTD · SPONSORED ADS CUSIP —
2026-03-31 filed 2026-05-15 +45d

src ↗

$7.5M

250,082

0.2%

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

TENET HEALTHCARE CORP · COM NEW CUSIP —
2026-03-31 filed 2026-05-15 +45d

src ↗

$7.2M

38,269

0.2%

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

10X GENOMICS INC · CL A COM CUSIP —
2026-03-31 filed 2026-05-15 +45d

src ↗

$7.0M

329,492

0.2%

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

CVS HEALTH CORP · COM CUSIP —
2026-03-31 filed 2026-05-15 +45d

src ↗

$6.4M

89,363

0.2%

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

NATERA INC · COM CUSIP —
2026-03-31 filed 2026-05-15 +45d

src ↗

$6.3M

31,694

0.2%

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

WAYSTAR HLDG CORP · COM CUSIP —
2026-03-31 filed 2026-05-15 +45d

src ↗

$6.2M

256,139

0.1%

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

MEDLINE INC · COM CL A CUSIP —
2026-03-31 filed 2026-05-15 +45d

src ↗

$6.1M

136,635

0.1%

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

INSPIRE MED SYS INC · COM CUSIP —
2026-03-31 filed 2026-05-15 +45d

src ↗

$5.1M

99,735

0.1%

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

PRIVIA HEALTH GROUP INC · COM CUSIP —
2026-03-31 filed 2026-05-15 +45d

src ↗

$4.7M

226,703

0.1%

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

PENUMBRA INC · COM CUSIP —
2026-03-31 filed 2026-05-15 +45d

src ↗

$4.0M

12,267

0.1%

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

ATRIUM THERAPEUTICS INC · COM CUSIP —
2026-03-31 filed 2026-05-15 +45d

src ↗

$3.5M

263,096

0.1%

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

PFIZER INC · COM CUSIP —
2026-03-31 filed 2026-05-15 +45d

src ↗

$3.0M

107,635

0.1%

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

ILLUMINA INC · COM CUSIP —
2026-03-31 filed 2026-05-15 +45d

src ↗

$2.5M

20,223

0.1%

—

KESTRA MED TECHNOLOGIES LTD · SHS CUSIP G52441105
2026-03-31 filed 2026-05-15 +45d

src ↗

ticker not yet mapped

$2.3M

115,590

0.1%

—

OMADA HEALTH INC · COM CUSIP 68170A108
2026-03-31 filed 2026-05-15 +45d

src ↗

ticker not yet mapped

$2.0M

157,938

0.0%

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

BRIDGEBIO PHARMA INC · COM CUSIP —
2026-03-31 filed 2026-05-15 +45d

src ↗

$1.9M

25,377

0.0%

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

BIONTECH SE · SPONSORED ADS CUSIP —
2026-03-31 filed 2026-05-15 +45d

src ↗

$1.9M

20,851

0.0%

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

ROYALTY PHARMA PLC · SHS CLASS A CUSIP —
2026-03-31 filed 2026-05-15 +45d

src ↗

$1.8M

38,296

0.0%

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

STATE STR SPDR S&P 500 ETF T · TR UNIT CUSIP —
2026-03-31 filed 2026-05-15 +45d

src ↗

$1.8M

2,700

0.0%

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

INSMED INC · COM PAR $.01 CUSIP —
2026-03-31 filed 2026-05-15 +45d

src ↗

$1.6M

10,034

0.0%

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

MADRIGAL PHARMACEUTICALS INC · COM CUSIP —
2026-03-31 filed 2026-05-15 +45d

src ↗

$1.6M

3,040

0.0%

—

MASIMO CORP · COM CUSIP 574795100
2026-03-31 filed 2026-05-15 +45d

src ↗

ticker not yet mapped

$1.6M

8,753

0.0%

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

PROTAGONIST THERAPEUTICS INC · COM CUSIP —
2026-03-31 filed 2026-05-15 +45d

src ↗

$1.5M

14,447

0.0%

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

UNITED THERAPEUTICS CORP DEL · COM CUSIP —
2026-03-31 filed 2026-05-15 +45d

src ↗

$1.2M

2,077

0.0%

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

BEONE MEDICINES LTD · SPONSORED ADS CUSIP —
2026-03-31 filed 2026-05-15 +45d

src ↗

$1.1M

3,812

0.0%

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

PHREESIA INC · COM CUSIP —
2026-03-31 filed 2026-05-15 +45d

src ↗

$1.1M

130,992

0.0%

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

ADAPTIVE BIOTECHNOLOGIES COR · COM CUSIP —
2026-03-31 filed 2026-05-15 +45d

src ↗

$1.1M

76,181

0.0%

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

BRISTOL-MYERS SQUIBB CO · COM CUSIP —
2026-03-31 filed 2026-05-15 +45d

src ↗

$1.0M

17,038

0.0%

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

ENCOMPASS HEALTH CORP · COM CUSIP —
2026-03-31 filed 2026-05-15 +45d

src ↗

$951K

9,829

0.0%

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

NEWAMSTERDAM PHARMA COMPANY · ORDINARY SHARES CUSIP —
2026-03-31 filed 2026-05-15 +45d

src ↗

$885K

27,661

0.0%

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

APPLE INC · COM CUSIP —
2026-03-31 filed 2026-05-15 +45d

src ↗

$843K

3,320

0.0%

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

BILLIONTOONE INC · CL A CUSIP —
2026-03-31 filed 2026-05-15 +45d

src ↗

$833K

10,554

0.0%

—

MINERALYS THERAPEUTICS INC · COM CUSIP 603170101
2026-03-31 filed 2026-05-15 +45d

src ↗

ticker not yet mapped

$796K

29,374

0.0%

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

EQUINOR ASA · SPONSORED ADR CUSIP —
2026-03-31 filed 2026-05-15 +45d

src ↗

$742K

17,573

0.0%

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

EXXON MOBIL CORP · COM CUSIP —
2026-03-31 filed 2026-05-15 +45d

src ↗

$741K

4,370

0.0%

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

BP PLC · SPONSORED ADR CUSIP —
2026-03-31 filed 2026-05-15 +45d

src ↗

$735K

15,644

0.0%

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

SHELL PLC · SPON ADS CUSIP —
2026-03-31 filed 2026-05-15 +45d

src ↗

$729K

7,844

0.0%

1–20 of the 100 issuers on this page

Change kind and share change are in Position changes above; Congress overlap is planned.

One line per issuer, largest first; a row with no issuer key stands on its own line. Open a line for its rows as this filer reported them. The list holds every row this filer reported for the quarter. Issuer totals on the holders pages count each manager's own report once; that never removes a row here. how positions are grouped ↗

Book shape

2026-03-31 · concentration · vs tracked median · tick = median

Top-25 concentration: 72.7%below median 80.0%
Concentration index: 278 bpsbelow median 446 bps
Positions with value: 167 / 167median book 97.5 positions

Concentration uses reported 13F long value, not total assets. The index is withheld when any position lacks a value. Medians are over the 8,748 tracked filers with a 2026-03-31 book; the index median over the 8,662 with a complete book.

holdings whose <value> did not parse — retained and counted, never zero-filled: 0 · share of the period's disclosed value held in the top-N positions; denominator is reported 13F value, not total assets: 72.7% · integer Herfindahl–Hirschman index in basis points over disclosed position values: 278 · QoQ moves: 195

Filing history

AVAILABLE QUARTERS

Available filing periods
Period	Source
2026-03-31	EDGAR ↗

PLANNED sector rotation · Congress overlap · signals for this filer

Complete source filings on SEC EDGAR

The complete filing on EDGAR.

The position list above is served from the published Public Filings build, each position as this filer reported it; where the page cannot embed every reported row, the list says how many it leaves out. This block is provenance, not a substitute: the filing itself is the record, and it is one click away. Public Filings decided on 2026-08-01 to serve this list from its published build; filings newer than this build are on EDGAR.

Open Bellevue Group AG's 13F filings on SEC EDGAR ↗

Notes on this data

Reported positions

Quarter-end holdings as filed

Explore the full published position list and its source filing. This record excludes the manager’s cash, shorts and non-13(f) assets.

Share changes

Compare consecutive quarters

Position changes retain the producer’s classification and comparability flags. Share counts and reported values describe different changes.

Coverage

A snapshot, not current holdings

Use the quarter selector to inspect available periods. Unknown values stay unknown and each table states its coverage.

A 13F is a quarterly, long-only snapshot filed up to 45 days late — not current holdings. what a 13F covers ↗

13F reports cover LONG positions in Section 13(f) securities (US exchange-traded equities plus reportable options, warrants, certain convertibles) held by managers with at least $100M in such securities — so managers below that threshold are absent entirely. No short positions, no cash, no non-13(f) assets — not a full portfolio, and not a census of institutional ownership.

Positions are quarter-end snapshots filed up to 45 days late — not current holdings. A position may have been changed or closed before you ever see it, and is older still by however long ago that quarter ended.

Values are the manager's stated market value at quarter-end in era-dependent units (whole dollars for form versions effective 2023-01-03 onward, thousands before), normalized here to whole dollars with unit_basis carried on every record.

Affiliated managers may report the same position (otherManager), so one position can appear under more than one filer.

Positions under confidential treatment may be omitted until a later amendment discloses them.

These are disclosures, not investment advice (ARCHITECTURE.md §5.2 / M2-CONTRACT §5).